Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Pleurodesis by a Combination of Bleomycin and Tranxemic Acid Solution and Thoracoscopic Talc Poudrage in Malignant Pleural Effusion

NCT06744946 is registered in ClinicalTrials.gov with Mohamed Sabry as lead sponsor.

NCT NCT06744946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06744946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Pleurodesis by a Combination of Bleomycin and Tranxemic Acid Solution and Thoracoscopic Talc Poudrage in Malignant Pleural Effusion
Lead sponsor
Mohamed Sabry
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2024
Completion date
December 4, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusions (mpe)- pleurodesis, pleurodesis